Name,Category,Begin Date,End Date,Note
Painless Jaundice,Milestones,2023-03-01,,Classic presentation
LFTs Elevated,Biomarker Assess,2023-03-05,,Obstructive pattern
CT Abdomen,Biomarker Assess,2023-03-08,,Distal bile duct mass 2.5cm
MRCP,Biomarker Assess,2023-03-12,,Confirms distal CBD stricture
EUS with FNA,Biomarker Assess,2023-03-15,,Adenocarcinoma confirmed
CA 19-9,Biomarker Assess,2023-03-18,,185 U/mL mildly elevated
Biliary Stent Placed,Milestones,2023-03-15,,ERCP with metal stent
PET-CT Staging,Biomarker Assess,2023-03-22,,No distant metastases
Molecular Testing,Biomarker Assess,2023-03-25,,No actionable mutations
Surgical Evaluation,Milestones,2023-03-28,,Deemed resectable
Whipple Procedure,Milestones,2023-04-12,,Pancreaticoduodenectomy R0 resection
Post-Op Complication,Complications,2023-04-20,,Delayed gastric emptying resolved
Pathology Final,Biomarker Assess,2023-04-25,,T2N1 2 of 18 nodes positive
Adjuvant Capecitabine,Line 1 treatment,2023-06-01,2023-12-01,6 months per BILCAP
CA 19-9 Normalized,Biomarker Assess,2023-07-15,,Down to 22 U/mL
3-Month Post-Chemo Scan,Milestones,2024-03-01,,No evidence of recurrence
6-Month Surveillance,Milestones,2024-06-01,,Remains NED
